Literature DB >> 28074016

CARI-7A: DEVELOPMENT AND VALIDATION.

Kyle Copeland1.   

Abstract

Aircrew members can be exposed to higher annual doses of natural ionizing radiation than members of the general population in most parts of the world. The principal ionizing radiation to which they are exposed is galactic cosmic radiation (GCR). Among the particles present in the primary spectrum are heavy ions: relativistic nuclei of lithium and heavier elements. These ions have very high radiation weighting factors and can contribute significantly to the effective dose at altitudes above the Pfotzer maximum. This report describes the latest version of the US Federal Aviation Administration's GCR flight dose calculation software, CARI-7A. Unlike its predecessor, CARI-6, CARI-7A directly includes heavy ion transport, using a database of atmospheric particle spectra generated by incident GCR ions pre-calculated with MCNPX 2.7.0. to enable calculations to the edge of space. Results are compared with measurements aboard commercial passenger aircraft, high altitude research aircraft and similar calculations by others. Published by Oxford University Press 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28074016     DOI: 10.1093/rpd/ncw369

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  Comments on "Incidence of cancer among licensed commercial pilots flying North Atlantic routes".

Authors:  S M J Mortazavi
Journal:  Environ Health       Date:  2017-11-17       Impact factor: 5.984

Review 2.  Space Radiation and Plasma Effects on Satellites and Aviation: Quantities and Metrics for Tracking Performance of Space Weather Environment Models.

Authors:  Yihua Zheng; Natalia Yu Ganushkina; Pier Jiggens; Insoo Jun; Matthias Meier; Joseph I Minow; T Paul O'Brien; Dave Pitchford; Yuri Shprits; W Kent Tobiska; Michael A Xapsos; Timothy B Guild; Joseph E Mazur; Maria M Kuznetsova
Journal:  Space Weather       Date:  2019-10-15       Impact factor: 4.456

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.